Vogt-Koyanagi-Harada syndrome

Autoimmunity Reviews

Volumn 12, Issue 11, 2013, Pages 1033-1038

  Greco, A ^a   Fusconi, M ^a   Gallo, A ^a   Turchetta, R ^a   Marinelli, C ^a   Macri, G F ^a   De Virgilio, A ^a   de Vincentiis, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Autoimmunity; Harada syndrome; Hearing loss; Hypoacusis; Uveitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BETAMETHASONE; BEVACIZUMAB; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN; INFLIXIMAB; MELANIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; RANIBIZUMAB; TRIAMCINOLONE;

ALLELE; ALOPECIA; AMERICAN INDIAN; ASIAN; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; EPSTEIN BARR VIRUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GROUPS BY AGE; HEARING IMPAIRMENT; HEREDITY; HISPANIC; HUMAN; IMMUNOMODULATION; LIVER DYSFUNCTION; MELANOCYTE; MENINGITIS; PATHOGENESIS; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEX RATIO; SKIN PIGMENTATION; T LYMPHOCYTE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; UVEITIS; VIRUS INFECTION; VITILIGO; VOGT KOYANAGI SYNDROME;

AUTOIMMUNITY; HARADA SYNDROME; HEARING LOSS; HYPOACUSIS; UVEITIS;

AUTOIMMUNE DISEASES; HLA-DRB1 CHAINS; HUMANS; SELF TOLERANCE; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 84881547049     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.01.004     Document Type: Review

References (62)

1. Moorthy R.S., Inomata H., Rao N.A. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995, 39:265-292.
2. Lucena D.R., Paula J.S., Silva G.C., Rodrigues L.Mde Incomplete Vogt-Koyanagi-Harada syndrome associated with HLA DRB1*01 in a 4-year-old child: case. Arq Bras Oftalmol 2007, 70:340-342.
3. Herbort C.P. Vogt-Koyanagi-Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and Japan. Int Ophthalmol 2007, 27:67-79.
4. Yang P., Ren Y., Li B., Fang W., Meng Q., Kijlstra A. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology 2007, 114:606-614.
5. Rajendram R., Evans M., Rao N.A. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin 2005, 45:115-134.
6. Sukavatcharin S., Tsai J.H., Rao N.A. Vogt-Koyanagi-Harada disease in Hispanic patients. Int Ophthalmol 2007, 27:143-148.
7. Damico F.M., Kiss S., Young L.H. Vogt-Koyanagi-Harada disease. Semin Ophthalmol 2005, 20:183-190.
8. Ondrey F.G., Moldestad E., Mastroianni M.A., Pikus A., Sklare D., Vernon E., et al. Sensorineural hearing loss in Vogt-Koyanagi-Harada syndrome. Laryngoscope 2006, 116:1873-1876.
9. Berker N., Ozdamar Y., Soykan E., Ozdal P., Ozkan S.S. Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature. Ocul Immunol Inflamm 2007, 15:351-357.
10. Tabbara K.F., Chavis P.S., Freeman W.R. Vogt-Koyanagi-Harada syndrome in children compared to adults. Acta Ophthalmol Scand 1998, 76:723-726.
11. Belfort Junior R., Nishi M., Hayashi S., Abreu M.T., Petrilli A.M., Plut R.C. Vogt-Koyanagi-Harada disease in Brazil. Jpn J Ophthalmol 1988, 32:344-347.
12. Blanc F., Fleury M., Talmant V., Deroide N., Szwarcberg J., Tranchant C. Vogt-Koyanagi-Harada syndrome. Rev Neurol 2005, 161:1079-1090.
13. Rao N.A., Gupta A., Dustin L., Chee S.P., Okada A.A., Khairallah M., et al. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology 2010, 117:591-599.
14. Ramos Macías A., Ruiz Martín F., Criado Martín D., Gómez González J.L., González M. Vogt-Koyanagi-Harada syndrome; a model of autoimmune neurosensory hypoacusia. Acta Otorrinolaringol Esp 1989, 40:247-250.
15. Vallés-Varela H. Goya, su sordera y su tiempo. Acta Otorrinolaringol Esp 2005, 56:122-131.
16. Juhn S., Rybak L., Jung T. Bioquímica del laberinto. Otorrinolaringología 1994, 619-662. Editorial Panamericana, Buenos Aires. 3rd ed. M. Paparella (Ed.).
17. Schuknecht H. Pathology of the ear 1993, Lea and Febiger, Philadelphia. 2nd ed.
18. Chee S.P., Luu C.D., Cheng C.L., Lim W.K., Jap A. Visual function in Vogt-Koyanagi-Harada patients. Graefes Arch Clin Exp Ophthalmol 2005, 243:785-790.
19. Ehrenfeld M. Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev 2010, 9:A325-A329.
20. Commodaro A.G., Bueno V., Belfort R., Rizzo L.V. Autoimmune uveitis: the associated proinflammatory molecules and the search for immunoregulation. Autoimmun Rev 2011, 10:205-209.
21. Greco A., Fusconi M., Gallo A., Marinelli C., Macri G.F., de Vincentiis M. Sudden sensorineural hearing loss: an autoimmune disease?. Autoimmun Rev 2011, 10:756-761.
22. García-Carrasco M., Jiménez-Hernández C., Jiménez-Hernández M., Voorduin-Ramos S., Mendoza-Pinto C., Ramos-Alvarez G., et al. Susac's syndrome: an update. Autoimmun Rev 2011 Jul, 10:548-552.
23. Trimarchi M., Sinico R.A., Teggi R., Bussi M., Specks U., Meroni P.L. Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener's). Autoimmun Rev Feb 2013, 12(4):501-505. Epub 2012 Aug 23. 10.1016/j.autrev.2012.08.010.
24. Greco A., Gallo A., Fusconi M., Marinelli C., Macri G.F., de Vincentiis M. Meniere's disease might be an autoimmune condition?. Autoimmun Rev Aug 2012, 11(10):731-738.
25. Greco A., Gallo A., Fusconi M., Magliulo G., Turchetta R., Marinelli C., et al. Cogan's syndrome: an autoimmune inner ear disease. Autoimmun Rev 2013, 12:396-400.
26. Duck S., Prazma J., Bennet P., Pillsburg H. Interaction between hypertension and diabetes mellitus in the pathogenesis of sensorineural hearing loss. Laryngoscope 1997, 107:1596-1605.
27. Yamaki K., Gocho K., Hayakawa K., Kondo I., Sukuragi S. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol 2000, 165:7323-7329.
28. Tagawa Y., Sugiura S., Yakura H., Wakisaka A., Aizawa M. Letter: HLA and Vogt-Koyanagi-Harada syndrome. N Engl J Med 1976, 295:173.
29. Davis J.L., Mittal K.K., Freidlin V., Mellow S.R., Optican D.C., Palestine G., et al. HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. Ophthalmology 1990, 97:1137-1142.
30. Goldberg A.C., Yamamoto J.H., Chiarella J.M., Marin M.L., Sibinelli M., Neufeld R., et al. HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease. Hum Immunol 1998, 59:183-188.
31. Damico F.N., Cunha-Neto E., Goldberg A.C., Iwai L.K., Marin M.L., Hammer J., et al. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis. Invest Ophthalmol Vis Sci 2005, 46:2465-2471.
32. Bassili S.S., Peyman G.A., Gebhardt B.M., Daun M., Ganiban G.J., Rifai A. Detection of Epstein-Barr virus DNA by polymerase chain reaction in the vitreous from a patient with Vogt-Koyanagi-Harada syndrome. Retina 1996, 16:160-161.
33. Sugita S., Takase H., Kawaguchi T., Taguchi C., Mochizuki M. Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease. Int Ophthalmol 2007, 27:87-95.
34. Hayasaka Y., Hayasaka S. Almost simultaneous onset of Vogt-Koyanagi-Harada syndrome in co-workers, friends, and neighbours. Graefes Arch Clin Exp Ophthalmol 2004, 242:611-613.
35. Rao N.A. Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome. Eye (Lond) 1997, 11(Pt 2):213-216.
36. Savin C. The blood vessels and pigmentary cells of the inner ear. Ann Otol Rhinol Laryngol 1965, 74:1-12.
37. Maezawa N., Yano A., Taniguchi M., Kojima S. The role of cytotoxic T lymphocytes in the pathogenesis of Vogt-Koyanagi-Harada disease. Ophthalmologica 1982, 185:179-186.
38. Yamaki K., Gocho K., Sakuragi S. Pathogenesis of Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin 2002, 42:13-23.
39. Yamaki K., Kondo I., Nakamura H., Miyano M., Konno S., Sakuragi S. Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats. Exp Eye Res 2000, 71:361-369.
40. Otani S., Sakurai T., Yamamoto K., Fujita T., Matsuzaki Y., Goto Y., et al. Frequent immune response to a melanocyte-specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol 2006, 90:773-777.
41. Chi W., Yang P., Li B., Wu C., Jin H., Zhu X., et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol 2007, 119:1218-1224.
42. Chen L., Yang P., Zhou H., He H., Ren X., Chi W., et al. Diminished frequency and function of CD4+ CD25 high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci 2008, 49:3475-3482.
43. Kimura H., Ohashi N., Aso S., Watanabe Y. Clinical study of the role of melanocytes in the inner ear of patients with Harada disease. ORL J Otorhinolaryngol Relat Spec 1996, 58:233-237.
44. McCabe B.F. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979, 88:585-589.
45. Harris J.P., Weisman M.H., Derebery J.M., Espeland M.A., Gantz B.J., Gulya A.J., et al. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA 2003, 290:1875-1883.
46. Chan C.C., Palestine A.G., Kuwabara T., Nussenblatt R.B. Immunopathologic study of Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1988, 105:607-611.
47. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
48. Damico F.M., Bezerra F.T., Silva G.C., Gasparin F., Yamamoto J.H. New insights into Vogt-Koyanagi-Harada disease. Arq Bras Oftalmol 2009, 72:413-420.
49. Andreoli C.M., Foster C.S. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin 2006, 46:111-122.
50. Chee S.P., Jap A., Bacsal K. Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore. Am J Ophthalmol 2009, 147:154-161.
51. Read R.W., Yu F., Accorinti M., Bodaghi B., Chee S.P., Fardeau C., et al. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2006, 142:119-124.
52. Ikeda K., Suzuki S., Ichijo M. How high is high in steroid treatment of Vogt-Koyanagi-Harada syndrome?. Neurology 1997, 48:537.
53. Yamanaka E., Ohguro N., Yamamoto S., Nakagawa Y., Imoto Y., Tano Y. Evaluation of pulse corticosteroid therapy for Vogt-Koyanagi-Harada disease assessed by optical coherence tomography. Am J Ophthalmol 2002, 134:454-456.
54. Lustig M.J., Cunningham E.T. Use of immunosuppressive agents in uveitis. Curr Opin Ophthalmol 2003, 14:399-412.
55. Goldstein D.A., Fontanilla F.A., Kaul S., Sahin O., Tessler H.H. Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammation. Ophthalmology 2002, 109:370-377.
56. Agarwal M., Ganesh S.K., Biswas J. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome. Ocul Immunol Inflamm 2006, 14:333-339.
57. Andrade R.E., Muccioli C., Farah M.E., Nussenblatt R.B., Belfort R. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 2004, 137:572-574.
58. Imrie F.R., Dick A.D. Biologic in the treatment of uveitis. Curr Opin Ophthalmol 2007, 18:481-486.
59. Díaz Llopis M., Amselem L., Romero F.J., García-Delpech S., Hernández M.L. Adalimumab therapy for Vogt-Koyanagi-Harada syndrome. Arch Soc Esp Oftalmol 2007, 82:131-132.
60. Rodrigues E.B., Farah M.E., Maia M., Penha F.M., Regatieri C., Melo G.B., et al. Therapeutic monoclonal antibodies in ophthalmology. Prog Retin Eye Res 2009, 28:117-144.
61. Wu L., Evans T., Saravia M., Schlaen A., Couto C. Intravitreal bevacizumab for choroidal neovascularization secondary to Vogt-Koyanagi-Harada syndrome. Jpn J Ophthalmol 2009, 53:57-60.
62. Helveston W.R., Gilmore R. Treatment of Vogt-Koyanagi-Harada syndrome with intravenous immunoglobulin. Neurology 1996, 46:584-585.